1 Clindamycin Phosphate for Vaginal Market Overview 1.1 Product Overview and Scope of Clindamycin Phosphate for Vaginal 1.2 Clindamycin Phosphate for Vaginal Segment by Type 1.2.1 Global Clindamycin Phosphate for Vaginal Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Vaginal Suppositories 1.2.3 Vaginal Cream 1.3 Clindamycin Phosphate for Vaginal Segment by Application 1.3.1 Global Clindamycin Phosphate for Vaginal Sales Comparison by Application: (2021-2027) 1.3.2 Hospital 1.3.3 Drug Store 1.4 Global Clindamycin Phosphate for Vaginal Market Size Estimates and Forecasts 1.4.1 Global Clindamycin Phosphate for Vaginal Revenue 2016-2027 1.4.2 Global Clindamycin Phosphate for Vaginal Sales 2016-2027 1.4.3 Clindamycin Phosphate for Vaginal Market Size by Region: 2016 Versus 2021 Versus 2027 2 Clindamycin Phosphate for Vaginal Market Competition by Manufacturers 2.1 Global Clindamycin Phosphate for Vaginal Sales Market Share by Manufacturers (2016-2021) 2.2 Global Clindamycin Phosphate for Vaginal Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Clindamycin Phosphate for Vaginal Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Clindamycin Phosphate for Vaginal Manufacturing Sites, Area Served, Product Type 2.5 Clindamycin Phosphate for Vaginal Market Competitive Situation and Trends 2.5.1 Clindamycin Phosphate for Vaginal Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Clindamycin Phosphate for Vaginal Players Market Share by Revenue 2.5.3 Global Clindamycin Phosphate for Vaginal Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Clindamycin Phosphate for Vaginal Retrospective Market Scenario by Region 3.1 Global Clindamycin Phosphate for Vaginal Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Clindamycin Phosphate for Vaginal Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Clindamycin Phosphate for Vaginal Market Facts & Figures by Country 3.3.1 North America Clindamycin Phosphate for Vaginal Sales by Country 3.3.2 North America Clindamycin Phosphate for Vaginal Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Clindamycin Phosphate for Vaginal Market Facts & Figures by Country 3.4.1 Europe Clindamycin Phosphate for Vaginal Sales by Country 3.4.2 Europe Clindamycin Phosphate for Vaginal Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Clindamycin Phosphate for Vaginal Market Facts & Figures by Region 3.5.1 Asia Pacific Clindamycin Phosphate for Vaginal Sales by Region 3.5.2 Asia Pacific Clindamycin Phosphate for Vaginal Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Clindamycin Phosphate for Vaginal Market Facts & Figures by Country 3.6.1 Latin America Clindamycin Phosphate for Vaginal Sales by Country 3.6.2 Latin America Clindamycin Phosphate for Vaginal Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Clindamycin Phosphate for Vaginal Market Facts & Figures by Country 3.7.1 Middle East and Africa Clindamycin Phosphate for Vaginal Sales by Country 3.7.2 Middle East and Africa Clindamycin Phosphate for Vaginal Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Clindamycin Phosphate for Vaginal Historic Market Analysis by Type 4.1 Global Clindamycin Phosphate for Vaginal Sales Market Share by Type (2016-2021) 4.2 Global Clindamycin Phosphate for Vaginal Revenue Market Share by Type (2016-2021) 4.3 Global Clindamycin Phosphate for Vaginal Price by Type (2016-2021) 5 Global Clindamycin Phosphate for Vaginal Historic Market Analysis by Application 5.1 Global Clindamycin Phosphate for Vaginal Sales Market Share by Application (2016-2021) 5.2 Global Clindamycin Phosphate for Vaginal Revenue Market Share by Application (2016-2021) 5.3 Global Clindamycin Phosphate for Vaginal Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Clindamycin Phosphate for Vaginal Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Pfizer Clindamycin Phosphate for Vaginal Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 Perrigo 6.2.1 Perrigo Corporation Information 6.2.2 Perrigo Description and Business Overview 6.2.3 Perrigo Clindamycin Phosphate for Vaginal Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Perrigo Clindamycin Phosphate for Vaginal Product Portfolio 6.2.5 Perrigo Recent Developments/Updates 7 Clindamycin Phosphate for Vaginal Manufacturing Cost Analysis 7.1 Clindamycin Phosphate for Vaginal Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Clindamycin Phosphate for Vaginal 7.4 Clindamycin Phosphate for Vaginal Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Clindamycin Phosphate for Vaginal Distributors List 8.3 Clindamycin Phosphate for Vaginal Customers 9 Clindamycin Phosphate for Vaginal Market Dynamics 9.1 Clindamycin Phosphate for Vaginal Industry Trends 9.2 Clindamycin Phosphate for Vaginal Growth Drivers 9.3 Clindamycin Phosphate for Vaginal Market Challenges 9.4 Clindamycin Phosphate for Vaginal Market Restraints 10 Global Market Forecast 10.1 Clindamycin Phosphate for Vaginal Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Clindamycin Phosphate for Vaginal by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Clindamycin Phosphate for Vaginal by Type (2022-2027) 10.2 Clindamycin Phosphate for Vaginal Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Clindamycin Phosphate for Vaginal by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Clindamycin Phosphate for Vaginal by Application (2022-2027) 10.3 Clindamycin Phosphate for Vaginal Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Clindamycin Phosphate for Vaginal by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Clindamycin Phosphate for Vaginal by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Clindamycin Phosphate for Vaginal Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Clindamycin Phosphate for Vaginal Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Clindamycin Phosphate for Vaginal Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Clindamycin Phosphate for Vaginal Covered in This Study Table 5. Global Clindamycin Phosphate for Vaginal Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Clindamycin Phosphate for Vaginal Sales Market Share by Manufacturers (2016-2021) Table 7. Global Clindamycin Phosphate for Vaginal Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Clindamycin Phosphate for Vaginal Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Clindamycin Phosphate for Vaginal Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Clindamycin Phosphate for Vaginal Manufacturing Sites and Area Served Table 11. Manufacturers Clindamycin Phosphate for Vaginal Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Clindamycin Phosphate for Vaginal by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clindamycin Phosphate for Vaginal as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Clindamycin Phosphate for Vaginal Sales by Region (2016-2021) & (K Units) Table 16. Global Clindamycin Phosphate for Vaginal Sales Market Share by Region (2016-2021) Table 17. Global Clindamycin Phosphate for Vaginal Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Clindamycin Phosphate for Vaginal Sales by Country (2016-2021) & (K Units) Table 19. North America Clindamycin Phosphate for Vaginal Sales Market Share by Country (2016-2021) Table 20. North America Clindamycin Phosphate for Vaginal Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Clindamycin Phosphate for Vaginal Revenue Market Share by Country (2016-2021) Table 22. Europe Clindamycin Phosphate for Vaginal Sales by Country (2016-2021) & (K Units) Table 23. Europe Clindamycin Phosphate for Vaginal Sales Market Share by Country (2016-2021) Table 24. Europe Clindamycin Phosphate for Vaginal Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Clindamycin Phosphate for Vaginal Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Clindamycin Phosphate for Vaginal Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Clindamycin Phosphate for Vaginal Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Clindamycin Phosphate for Vaginal Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Clindamycin Phosphate for Vaginal Revenue Market Share by Region (2016-2021) Table 30. Latin America Clindamycin Phosphate for Vaginal Sales by Country (2016-2021) & (K Units) Table 31. Latin America Clindamycin Phosphate for Vaginal Sales Market Share by Country (2016-2021) Table 32. Latin America Clindamycin Phosphate for Vaginal Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Clindamycin Phosphate for Vaginal Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Clindamycin Phosphate for Vaginal Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Clindamycin Phosphate for Vaginal Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Clindamycin Phosphate for Vaginal Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Clindamycin Phosphate for Vaginal Revenue Market Share by Country (2016-2021) Table 38. Global Clindamycin Phosphate for Vaginal Sales (K Units) by Type (2016-2021) Table 39. Global Clindamycin Phosphate for Vaginal Sales Market Share by Type (2016-2021) Table 40. Global Clindamycin Phosphate for Vaginal Revenue (Million US$) by Type (2016-2021) Table 41. Global Clindamycin Phosphate for Vaginal Revenue Share by Type (2016-2021) Table 42. Global Clindamycin Phosphate for Vaginal Price (USD/Unit) by Type (2016-2021) Table 43. Global Clindamycin Phosphate for Vaginal Sales (K Units) by Application (2016-2021) Table 44. Global Clindamycin Phosphate for Vaginal Sales Market Share by Application (2016-2021) Table 45. Global Clindamycin Phosphate for Vaginal Revenue (Million US$) by Application (2016-2021) Table 46. Global Clindamycin Phosphate for Vaginal Revenue Share by Application (2016-2021) Table 47. Global Clindamycin Phosphate for Vaginal Price (USD/Unit) by Application (2016-2021) Table 48. Pfizer Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Clindamycin Phosphate for Vaginal Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Pfizer Clindamycin Phosphate for Vaginal Product Table 52. Pfizer Recent Developments/Updates Table 53. Perrigo Corporation Information Table 54. Perrigo Description and Business Overview Table 55. Perrigo Clindamycin Phosphate for Vaginal Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Perrigo Clindamycin Phosphate for Vaginal Product Table 57. Perrigo Recent Developments/Updates Table 58. Production Base and Market Concentration Rate of Raw Material Table 59. Key Suppliers of Raw Materials Table 60. Clindamycin Phosphate for Vaginal Distributors List Table 61. Clindamycin Phosphate for Vaginal Customers List Table 62. Clindamycin Phosphate for Vaginal Market Trends Table 63. Clindamycin Phosphate for Vaginal Growth Drivers Table 64. Clindamycin Phosphate for Vaginal Market Challenges Table 65. Clindamycin Phosphate for Vaginal Market Restraints Table 66. Global Clindamycin Phosphate for Vaginal Sales Forecast by Type (2022-2027) & (K Units) Table 67. Global Clindamycin Phosphate for Vaginal Sales Market Share Forecast by Type (2022-2027) Table 68. Global Clindamycin Phosphate for Vaginal Revenue Forecast by Type (2022-2027) & (US$ Million) Table 69. Global Clindamycin Phosphate for Vaginal Revenue Market Share Forecast by Type (2022-2027) Table 70. Global Clindamycin Phosphate for Vaginal Sales Forecast by Application (2022-2027) & (K Units) Table 71. Global Clindamycin Phosphate for Vaginal Sales Market Share Forecast by Application (2022-2027) Table 72. Global Clindamycin Phosphate for Vaginal Revenue Forecast by Application (2022-2027) & (US$ Million) Table 73. Global Clindamycin Phosphate for Vaginal Revenue Market Share Forecast by Application (2022-2027) Table 74. Global Clindamycin Phosphate for Vaginal Sales Forecast by Region (2022-2027) & (K Units) Table 75. Global Clindamycin Phosphate for Vaginal Sales Market Share Forecast by Region (2022-2027) Table 76. Global Clindamycin Phosphate for Vaginal Revenue Forecast by Region (2022-2027) & (US$ Million) Table 77. Global Clindamycin Phosphate for Vaginal Revenue Market Share Forecast by Region (2022-2027) Table 78. Research Programs/Design for This Report Table 79. Key Data Information from Secondary Sources Table 80. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Clindamycin Phosphate for Vaginal Figure 2. Global Clindamycin Phosphate for Vaginal Market Share by Type in 2020 & 2027 Figure 3. Vaginal Suppositories Product Picture Figure 4. Vaginal Cream Product Picture Figure 5. Global Clindamycin Phosphate for Vaginal Market Share by Application in 2020 & 2027 Figure 6. Hospital Figure 7. Drug Store Figure 8. Global Clindamycin Phosphate for Vaginal Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Clindamycin Phosphate for Vaginal Market Size 2016-2027 (US$ Million) Figure 10. Global Clindamycin Phosphate for Vaginal Sales 2016-2027 (K Units) Figure 11. Global Clindamycin Phosphate for Vaginal Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 12. Clindamycin Phosphate for Vaginal Sales Share by Manufacturers in 2020 Figure 13. Global Clindamycin Phosphate for Vaginal Revenue Share by Manufacturers in 2020 Figure 14. The Global 5 and 10 Largest Clindamycin Phosphate for Vaginal Players: Market Share by Revenue in 2020 Figure 15. Clindamycin Phosphate for Vaginal Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 16. Global Clindamycin Phosphate for Vaginal Sales Market Share by Region (2016-2021) Figure 17. Global Clindamycin Phosphate for Vaginal Sales Market Share by Region in 2020 Figure 18. Global Clindamycin Phosphate for Vaginal Revenue Market Share by Region (2016-2021) Figure 19. Global Clindamycin Phosphate for Vaginal Revenue Market Share by Region in 2020 Figure 20. U.S. Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 21. Canada Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Germany Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. France Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. U.K. Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Italy Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Russia Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. China Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Japan Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. South Korea Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. India Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Australia Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Taiwan Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Indonesia Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Thailand Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Malaysia Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Philippines Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Vietnam Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Mexico Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Brazil Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Argentina Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Turkey Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Saudi Arabia Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. U.A.E Clindamycin Phosphate for Vaginal Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Sales Market Share of Clindamycin Phosphate for Vaginal by Type (2016-2021) Figure 45. Sales Market Share of Clindamycin Phosphate for Vaginal by Application (2016-2021) Figure 46. Sales Market Share of Clindamycin Phosphate for Vaginal by Application in 2020 Figure 47. Revenue Share of Clindamycin Phosphate for Vaginal by Application (2016-2021) Figure 48. Revenue Share of Clindamycin Phosphate for Vaginal by Application in 2020 Figure 49. Manufacturing Cost Structure of Clindamycin Phosphate for Vaginal Figure 50. Manufacturing Process Analysis of Clindamycin Phosphate for Vaginal Figure 51. Clindamycin Phosphate for Vaginal Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Pfizer Perrigo